Narus Financial Partners, LLC

Position in JNJ — Johnson & Johnson

CIK 1698091 SALT LAKE CITY, UT

Position in JNJ

as of Jun 30, 2026 · filed Jul 31, 2026 Compact

Position Value

$260,065

+$27,359 QoQ

Shares Held

1,024

+7.6% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.11%

of 13F equity value

Holder Rank

#4,305

of 4,664 holders

Holding Since

Mar 2021

7 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Narus Financial Partners, LLC holds $2,295,659 across 6 Drug Manufacturers - General names. JNJ ranks #5 (11.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	2,388	$600,916
2	LLY	ELI LILLY & Co	437	$524,150
3	BMY	Bristol Myers Squibb Co	6,636	$382,366
4	NVS	Novartis AG	1,889	$296,044
5	JNJ	Johnson & Johnson This page	1,024	$260,065
6	AMGN	Amgen Inc	641	$232,118

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$260,065	1,024	+7.6%	Shares	Sole	2026-07-31
2026-03-31	$232,706	952	-31.1%	Shares	Sole	2026-04-21
2022-12-31	$243,953	1,381	-7.3%	Shares	Sole	2023-10-12
2022-09-30	$243,243	1,489	+0.5%	Shares	Sole	2023-10-12
2022-06-30	$262,892	1,481	+1.2%	Shares	Sole	2023-10-12
2022-03-31	$259,464	1,464	-4.7%	Shares	Sole	2023-09-12
2021-03-31	$252,441	1,536	—	Shares	Sole	2024-03-07
No filing history on record for this holder in this stock.